India Quarterly Results BSE NSE Announcements — May 21, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

1. To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the Standalone and Consolidated financial results for the quarter and year ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the Audited Standalone and Consolidated Financial Results and to Recommend the Final Dividend for the financial year ended on March 31, 2026, if any

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026, Fund Raising and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

Board Meeting Intimation to consider and approve and take on record the financial results (Standalone and Consolidated) for the period ended March 31, 2026.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the Audited financial results (Standalone & Consolidated) for the quarter and year ended 31st March, 2026 and to transact any other business with the permission of Chair.

to consider and approve & take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on March 31, 2026 as per Regulation 33 of the Listing Regulation along with other businesses as may be decided by the Board.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the Annual Standalone and Consolidated Financial Results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and final dividend for FY 2025-26.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Year ended March 31, 2026 and To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026, and payment of final dividend for the financial year ended March 31, 2026, if any; subject to approval of shareholders at the ensuing AGM.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the audited financial results for the quarter and financial year ended March 31, 2026 and recommendation of final dividend for the financial year 2025-26

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve Audited financial results for the the fourth quarter and financial year ended March 31, 2026, recommed dividend, if any, and other business matters

Intimation of the Board of Directors , to inter-alia, consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Year ended 31st March, 2026 and to recommend dividend for the Year ended 31st March, 2026.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the quarter and financial year ended March 31, 2026

To consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2026

To consider and approve the financial results for the quarter and financial year ended March 31, 2026 and final dividend, if any.

To consider and approve the financial results for the period ended March 31, 2026

COMPLIANCE OF REGULATION 29 (1) (A) & 50 (1) (C) OF SEBI (LODR) REGULATIONS, 2015 INTIMATION OF BOARD MEETING FOR APPROVING THE AUDITED FINANCIAL STATEMENTS(STANDALONE & CONSOLIDATED) FOR THE FINANCIAL YEAR ENDED MARCH 31, 2026.

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the quarter and financial year ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the Audited Financial Results for the financial year ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the audited standalone and consolidated Financial Results of the Company for the quarter and year ended March 31, 2026 and dividend/Fund Raising.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the Audited financial results for the Quarter and Year ended March 31, 2026

Intimation of Board Meeting

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026, Fund Raising and other business matters

To consider and approve the financial results for the period ended March 31, 2026, dividend and Fund Raising

To consider and approve the financial results for the period ended March 31, 2026 and dividend

to, inter alia, consider, approve and take on record, the Audited Financial Results for the quarter and financial year ended on March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the Audited financial results for the quarter and year ended March 31, 2026 and declaration of Final dividend, if any

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year March 31, 2026.

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026.

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the audited financial results and recommendation of final dividend, if any, for the year ended March 31, 2026.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the audited financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

to consider and approve the standalone as well as the consolidated audited financialresults of the Company for the quarter and financial year ended March 31, 2026 and recommend Final Dividend, if any, on Equity Shares of the Company for the financial year ended March 31, 2026.

to consider and approve the audited standalone and consolidated financial results of the Company for the quarter and financial year ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the Audited financial results for the period ended March 31, 2026 and recommendation of dividend, if any.